BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33977961)

  • 1. Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome
    Li X; Liu Q; Yu J; Zhang R; Sun T; Jiang W; Hu N; Yang P; Luo L; Ren J; Wang Q; Wang Y; Yang Q
    Food Funct; 2021 May; 12(9):4142-4151. PubMed ID: 33977961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2.
    Gao J; Xiong T; Grabauskas G; Owyang C
    Gastroenterology; 2022 Jun; 162(7):1962-1974.e6. PubMed ID: 35167867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.
    Yu Y; Wu S; Li J; Wang R; Xie X; Yu X; Pan J; Xu Y; Zheng L
    Metab Brain Dis; 2015 Feb; 30(1):47-55. PubMed ID: 24807589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic N-methyl-d-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome.
    Qi Q; Chen F; Zhang W; Wang P; Li Y; Zuo X
    J Gastroenterol Hepatol; 2017 Apr; 32(4):828-836. PubMed ID: 27575648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
    Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
    Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Chang'an No. I Recipe on 5-hydroxytryptamine Signal System and mRNA Expression Levels of Hippocampal Brain Derived Neurotrophic Factor in Visceral Hypersensitivity Rats with Irritable Bowel Syndrome].
    Zhao YP; Su M; Wang FY; Bian ZX; Yang JQ; Wang W; Tang XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1228-35. PubMed ID: 26677676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
    Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N
    World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.
    Foley S; Garsed K; Singh G; Duroudier NP; Swan C; Hall IP; Zaitoun A; Bennett A; Marsden C; Holmes G; Walls A; Spiller RC
    Gastroenterology; 2011 May; 140(5):1434-43.e1. PubMed ID: 21315720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
    Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
    Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
    Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
    World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ketogenic Diet Improves Gut-Brain Axis in a Rat Model of Irritable Bowel Syndrome: Impact on 5-HT and BDNF Systems.
    Orlando A; Chimienti G; Notarnicola M; Russo F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.
    Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Lindsey PJ; Dekker J; Buurman WA; Masclee AA
    Aliment Pharmacol Ther; 2014 Aug; 40(4):392-402. PubMed ID: 24943480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF modulates intestinal barrier integrity through regulating the expression of tight junction proteins.
    Yu YB; Zhao DY; Qi QQ; Long X; Li X; Chen FX; Zuo XL
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27747999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.